2023
COVID-19 Infections and Predictors of Sickness Related Absences Among Healthcare Workers
Sakr C, Fakih L, Melhem N, Fakhreddine M, Musharrafieh U, Banna H, Doudakian R, Zahreddine N, Tannous J, Kanj S, Slade M, Redlich C, Rahme D. COVID-19 Infections and Predictors of Sickness Related Absences Among Healthcare Workers. Journal Of Occupational And Environmental Medicine 2023, 65: 590-594. PMID: 37015731, PMCID: PMC10332510, DOI: 10.1097/jom.0000000000002857.Peer-Reviewed Original ResearchConceptsCOVID-19 infectionHealthcare workersSick leave daysLeave daysSick leaveCross-sectional study designMonths of infectionLonger sick leaveCOVID-19Public health interventionsRegression analysisLinear regression analysisHealth interventionsStudy designInfectionSick leavesRelated absencesFuture pandemicsCOVID-19 pandemicPredictorsPandemicDaysLeaveNursesMonths
2022
Development and Application of a Polydimethylsiloxane-Based Passive Air Sampler to Assess Personal Exposure to SARS-CoV‑2
Angel D, Gao D, DeLay K, Lin E, Eldred J, Arnold W, Santiago R, Redlich C, Martinello R, Sherman J, Peccia J, Pollitt K. Development and Application of a Polydimethylsiloxane-Based Passive Air Sampler to Assess Personal Exposure to SARS-CoV‑2. Environmental Science & Technology Letters 2022, 9: 153-159. PMID: 37566382, PMCID: PMC8768000, DOI: 10.1021/acs.estlett.1c00877.Peer-Reviewed Original ResearchSARS-CoV-2Personal exposureAirborne SARS-CoV-2 RNASARS-CoV-2 exposureHigh-risk transmission areasSARS-CoV-2 RNAInfection control protocolsHigh-risk settingsVirus-laden aerosolsRespiratory virusesViral exposurePassive samplersExposure assessment toolsCommunity transmissionRespiratory dropletsInfectious virusEarly detectionViral loadingTransmission areasViral concentrationElectrical powerCOVID-19RNA/VirusDrum experiments
2020
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study
Mahajan S, Srinivasan R, Redlich CA, Huston SK, Anastasio KM, Cashman L, Massey DS, Dugan A, Witters D, Marlar J, Li SX, Lin Z, Hodge D, Chattopadhyay M, Adams MD, Lee C, Rao LV, Stewart C, Kuppusamy K, Ko AI, Krumholz HM. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study. The American Journal Of Medicine 2020, 134: 526-534.e11. PMID: 33130124, PMCID: PMC7598362, DOI: 10.1016/j.amjmed.2020.09.024.Peer-Reviewed Original ResearchConceptsSARS-CoV-2-specific IgG antibodiesWeighted seroprevalenceIgG antibodiesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodiesSARS-CoV-2-specific antibodiesConnecticut residentsSelf-reported adherenceImmunoglobulin G antibodiesSARS-CoV-2Symptomatic illnessSerology testingSeroprevalence studyG antibodiesPrevalence studyGeneral populationPercentage of peopleSeroprevalenceLack antibodiesMajority of respondentsAntibodiesHispanic subpopulationsConvenience sampleHispanic populationCOVID-19Risk mitigation behaviors